Synthetic melanin to speed wound healing
Synthetic Melanin for Accelerating Wound Repair
A topical synthetic melanin treatment that aims to reduce skin damage and help people with mustard-gas-related skin burns heal faster.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northwestern University NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-11182630 on NIH RePORTER |
What this research studies
This project develops a persistent antioxidant that mimics natural skin melanin and is applied topically to chemical-burn wounds caused by mustard agents. Researchers use data from human skin samples previously exposed to nitrogen mustard to guide lab and animal experiments that test whether the melanin mimetic reduces inflammation and tissue damage. The team studies how the treatment affects immune cell activity, oxidative stress, and the skin’s repair processes. If results are promising, the work is intended to move toward translational steps that could lead to clinical testing in affected patients.
Who could benefit from this research
Good fit: People who have recently suffered skin burns from sulfur or nitrogen mustard or similar chemical exposures and have open wounds suitable for topical therapy would be the most relevant candidates.
Not a fit: People without chemical-induced skin injuries, those with only old healed scars, or patients whose wounds are primarily from unrelated causes (for example, some diabetic ulcers) are unlikely to benefit from this specific approach.
Why it matters
Potential benefit: If successful, the treatment could speed healing, reduce pain, and lessen scarring after mustard-agent skin injuries.
How similar studies have performed: Preliminary lab and animal studies and analyses of human-exposed skin samples support the concept, but topical synthetic melanin has not yet been proven effective in clinical trials.
Where this research is happening
Chicago, United States
- Northwestern University — Chicago, United States (Active)
Researchers
- Principal investigator: Lu, Kurt — Northwestern University
- Study coordinator: Lu, Kurt
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.